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Abstracts
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site Godinne, Neurosurgery Dept, Yvoir, Belgium, 4Centre Hospitalier 
Régional Sambre et Meuse, Neurosurgery Dept, Namur, Belgium, 5CHC 
Saint-Joseph, Neurosurgery Dept, Liège, Belgium, 6Katholieke Universiteit 
Leuven, Universitaire Ziekenhuis Leuven, Radiation Oncology Dept, 
Leuven, Belgium.
Background There is a body of evidence that the risk of leptomeningeal 
dissemination (LMD) is increased in the postoperative stereotactic radio-
therapy (SRT) of brain metastases (BM) compared to adjuvant whole brain 
radiotherapy (WBRT). The proposed mechanism is an iatrogenic tumor dis-
semination into the cerebrospinal fluid at time of surgery. Including a wider 
volume of meningeal wall and the entire surgical track in the definition of 
the postoperative SRT clinical target volume (CTV) to decrease LMD is still 
controversial. The aim of this study was to retrospectively analyze the out-
come of adjuvant SRT targeted at resection cavities of BM without previous 
WBRT. MATERIAL / METHODS: We reviewed 70 patients treated with 
postoperative SRT for BM. Stereotactic planning computed tomography and 
planning MRI were imported into iPlan RT image software for image regis-
tration and TV delineation. The CTV consisted of any residual enhancement 
and all resected cavity including a safety margin of 1 to 2 mm. Only in cases 
of superficial initial tumor with meningeal contact was the CTV enlarged to 
the adjacent meningeal wall, but never included edema or the entire surgical 
track. Patients underwent regular follow-up MRI. The cumulative incidence 
rates of LMD was retrospectively calculated as well as patterns of failure.  RE-
SULTS: The most common histological type was non small cell lung cancer in 
61.4%. There were 38.6% infratentorial locations and 37.2 % superficial le-
sions. En bloc resection was achieved in 60% and compete resection in 75.7%. 
After a median imaging follow up time of 16.7 months, 54.3% of patients 
experienced distant brain failure. LMD occurred in 9 of 70 patients (12.9 %) 
at a median time of 10.7 months. Survival without LMD was 88% at 1 year 
(IC 95% 79%-97%) and 82% at 2years (IC 95% 72%-94%). In three quarter of 
cases, LMD interested superficial lesions. In univariate analysis, survival rates 
without LMD at 1 year for superficial and deep lesions were 88 % and 94 
%, respectively (p=0.49). We report only one recurrence in the surgical track 
(1.42%). CONCLUSION: The risk of LMD was comparable to the literature 
(11–17%). Superficial lesions were slightly more likely to relapse in the men-
inges, but it was non-significant. The risk of recurrence in the surgical track is 
negligible. Our results do not support the current guidelines recommending the 
systematic inclusion of the surgical track and the related meninges in the CTV.
P03.03 DYNAMICS OF BRAIN METASTASIS CAVITIES BETWEEN 
RESECTION AND ADJUVANT STEREOTACTIC RADIOTHERAPY 
AND IMPACT OF THE DELAY ON LOCAL CONTROL
A. Mousli1, B. Bihin2, T. Gustin3, G. Koerts4,  
M. Mouchamps5, J. F. Daisne1,6; 1Université Catholique de Louvain, 
CHU-UCL-Namur site Sainte Elisabeth, Radiation Oncology Dept, 
Namur, Belgium, 2Université Catholique de Louvain, CHU-UCL-Namur 
site Godinne, Biostastics Unit, Yvoir, Belgium, 3Université Catholique de 
Louvain, CHU-UCL-Namur site Godinne, Neurosurgery Dept,, Yvoir, 
Belgium, 4Centre Hospitalier Régional Sambre et Meuse, Neurosurgery 
Dept,, Namur, Belgium, 5CHC Saint-Joseph, Neurosurgery Dept,, Liège, 
Belgium, 6Katholieke Universiteit Leuven, Universitaire Ziekenhuis Leuven, 
Radiation Oncology Dept,, Leuven, Belgium.
BACKGROUND: Adjuvant stereotactic radiotherapy (SRT) to the sur-
gical cavity of brain metastases (BM) improves the local control. An early 
post-operative irradiation is desirable to limit the risk of recurrence while 
delaying it might reduce the risk of radionecrosis by reducing the size of 
the target volume (TV) thanks to the cavity constriction. The purpose of 
our study was to examine cavity dynamics after resection to determine if 
delaying SRT influences cavity size as well as local progression (LP). MA-
TERIAL AND METHODS: We reviewed 70 BM resection cavities treated 
with adjuvant SRT. A preoperative, immediate postoperative and at the time 
of SRT, 3D T1-weigthed MRI, were available for all patients. The volumes 
were retrospectively calculated with the PACS software Telemis® version 4 
and the iPlan RT image software. For all cavities, the TV was obtained by 
expanding the cavity by a median margin of 2mm to account for micro-
scopic spread. The surgical track and edema areas were not included in the 
TV. The dynamic evolution of cavities and LP according to the delay of 
SRT were analyzed. RESULTS: The median time from surgery to SRT was 
27 days (3–99). The median preoperative and SRT cavity volumes were 7.2 
cc (ranges: 0.5–29.5) and 8 cc (ranges: 0.8–31), respectively. After margin 
expansion, the TV was increased to a median of 14.8 cc. The volumetric 
cavity changes were an increase by 2 cc in 35 %, whereas only 22.5 % 
decreased by 2 cc and 42.5% cavities were stable (defined as a change ≤2 
cc). We noted that 11% of volume change were attributable to the delay 
(r2 = 0.11). forty-seven patients were treated within a delay of 30 days and 
experienced early LP in 10.6 % against 20 % beyond 30  days (p= 0.6). 
CONCLUSION: In the interval between surgery and SRT, BM cavities dy-
namics are inconstant and unpredictable in function of time. Furthermore, 
delaying SRT may compromise local control, though the difference was not 
statistically significant due to the small size of our population. A preopera-
tive SRT strategy looks more promising by alleviating the problem of time 
and reducing the volume of irradiated brain.
P03.04 SIGNALING QUESTIONS ASSESSING BRAIN TUMOR 
PATIENTS’ DISTRESS IN CLINICAL ROUTINE - A FEASIBILITY 
STUDY
A. Hartoyo1, K. Lichtenthaeler1, E. Kurz1, T. Pantel1,  
C. Richter1, P. Scholz-Kreisel2, F. Ringel3, N. Keric3, M. Renovanz4; 
1Department of Neurosurgery, University Medical Center Mainz, Mainz, 
Germany, 2Institute of Medical Biostatistics, Epidemiology and Informatics, 
University Medical Center Mainz, Mainz, Germany, 3Department of 
Neurosurgery, University Medical Center Mainz, Mainz, Germany, 
4Interdisciplinary Division of Neurooncology, University Medical Center 
Tuebingen, Tuebingen, Germany.
BACKGROUND: Approximately 20%-35% of patients with intracra-
nial tumors show depressive symptoms and distress. Assessment in these pa-
tients remains challenging due to cognitive and/or neurological deficits. We 
developed 3 signaling questions in order to assess patients during patient-
doctor consultation. The aim is to implement them in clinical routine and 
to compare the results with patient reported outcome measures (PROMs) 
along disease trajectory. MATERIAL AND METHODS: Patients were pro-
spectively examined in a structured interview applying the 3 following ques-
tions: 1),,Has your mood worsened? (I)”; 2),,Are you strained by physical 
changes? (II)”; 3),,Has your faculty of thought decreased? (III)”. Simultan-
eously, patients filled in the Distress Thermometer (DT) and the EORTC 
QLQ-C30  + BN20. The first patient group was assessed twice pre- and 
postoperatively in the very early disease trajectory (A), the second patient 
group once in the outpatient setting during adjuvant therapy or follow-up 
(B). The results of the 3 signaling questions were compared to the results 
of the PROMs. RESULTS: A total of n=62 patients gave informed consent 
and n= 61 were assessed so far. In general, the signaling questions were feas-
ible to answer for all patients. However, patients frequently needed more 
detailed examples for symptoms emphasizing the intention of the question.
In group A (n= 20), patients had a mean age of 59 years, n= 12 (60%) 
were male. Main diagnoses were glioblastomas, meningiomas and metas-
tases. The results of the signaling questions did not reflect the screening by 
DT: N= 11 (55%) reported that their mood has worsened (I) prior to the op-
eration, which then improved to n= 5 (31%) patients afterwards. The same 
applied to physical changes (II, 10 (50%) vs. 7 (44%), as well as lower cog-
nition (III, 7 (35%) vs. 4 (25%) respectively). In contrast, mean DT (5.7 vs. 6 
after) as well as the mean number of positive responses to the problem lists 
on the DT was similar pre- and postoperatively (8.7 pre-op vs. 9.4 post-op).
Group B, (n= 41) consisted of patients harboring malignant gliomas, n= 
27 (66%) were male. Patients had a mean DT score = 6.8, n= 22 (53%) 
named a worse mood (I), n= 23 (56%) patients reported physical changes 
(II) and n= 22 (54%) patients reported lower cognition (III), global health 
scale (GHS) according to the EORTC instrument was 60 (0–100). The ma-
jority of patients with a DT ≥6 also reported strain in the signaling questions 
and had a lower mean GHS  =  54,8. DT ≥ 6 was linked to worse mood 
(I, Fishers exact, p=0.02). CONCLUSION: According to our preliminary 
data, the signaling questions seem to be more useful in the outpatient setting 
in glioma patients than perioperatively. “Has your mood worsened” was 
associated with higher burden according to DT. Screening in brain tumor 
patients could probably complemented by direct questions in order to avoid 
missing patients who are not able to fill in questionnaires.
P03.05 COULD SUSPECTED GLIOBLASTOMAS BE TREATED 
WITHOUT HYSTOLOGICAL DIAGNOSIS?
K. Cortés Mateus1, I. Valduvieco Ruíz1,  
E. Verger Fransoy1, E. Pineda Losada1,  
L. Oleaga Zufiria1, T. Pujol Farre1,  
J. González Sánchez1, L. Pedrosa Eguílaz2,  
F. Graus Ribas1, T. Barreto Zambrano1,  
D. Muñoz Guglielmetti1, C. Castro Cuevas1,  
E. Escudero López1, A. Lloret Puerto1,  
J. Sáez Beltrán1, C. Camacho López1, C. Conill Llobet1,  
G. Oses González1, S. Garrido Alcantud1, M. Mollà Armada1; 1Hospital 
Clínico de Barcelona, Barcelona, Spain, 2Institut d’Investigacions 
Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
BACKGROUND: Probable unresectable Glioblastomas (GB) diagnosed 
by imaging techniques withouth anatomo-pathological (ap) confirmation 
could be treated under standard treatment. We reported the outcomes from 
this strategy in our center after tumor board evaluation. MATERIAL AND 
METHODS: From January/10 to September/16, 303 patients (pt) with GB 
were assessed by tumor board, during the same period 66 patients were 
consecutive analyzed with suspected GB by radiological criteria without 
histological diagnosis. We focus in the last group and analyzed the demo-
graphic/radiological data, non-biopsy causes, treatment type (concomitant 
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